331729-40-9

Upstream product

• 3970-05-6 5-chloro-2-hydroxybenzylamine 
• 331729-64-7 2-(5-chloro-2-hydroxy-benzyl)isoindole-1,3-dione 
• 14716-89-3 3-methyl-5-isoxazolemethanol 
• 331729-41-0 2-[5-chloro-2-(3-methylisoxazol-5-ylmethoxy)benzyl]isoindole-1,3-dione 

Downstream Products

• 331727-55-0 CP-608039 
• 1007397-14-9 acetyl-((1S,2R,3S,4R)-4-{6-[5-chloro-2-(3-methyl-isoxazol-5-ylmethoxy)-benzylamino]-purin-9-yl}-2,3-dihydroxy-cyclopentyl)-carbamic acid tert-butyl ester 
• 331728-88-2 3-azido-5-{6-[5-chloro-2-(3-methylisoxazol-5-ylmethoxy) benzylamino]purin-9-yl}-4-hydroxytetrahydrofuran-2-carboxylic acid methylamide 

Relevant academic research and scientific papers

Compounds for the treatment of ischemia

A3 agonists, methods of using such A3 agonists and pharmaceutical compositions containing such A3 agonists. The A3 agonists are useful for the reduction of tissue damage resulting from tissue ischemia or hypoxia

3'-aminoadenosine-5'-uronamides: Discovery of the first highly selective agonist at the human adenosine A3 receptor

Selective adenosine A3 agonists have potential utility for the prevention of perioperative myocardial ischemic injury. Herein, we report on the discovery and synthesis of compound 7. This amino nucleoside agonist possesses unprecedented levels